Ligand profile
ZINC230402130
Virtual-screening candidate from ZINC.
Bound to: KP13_03141 — Uridine kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC230402130- UniProt (similar protein)
Q9BZX2- Tanimoto
- 1.000
- Target protein
- KP13_03141
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 153.3
- −1 ≤ LogP ≤ 5 -1.53
- MW ≤ 500 Da 269.2
- LogP ≤ 5 -1.53
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 153.3
Matches PAINS filter: azo_A(324). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
[N-]=[N+]=N[C@@H]1[C@H](O)[C@@H](CO)O[C@@H]1n1ccc(=O)[nH]c1=O[N-]=[N+]=N[C@@H]1[C@H](O)[C@@H](CO)O[C@@H]1n1ccc(=O)[nH]c1=O
InChI=1S/C9H11N5O5/c10-13-12-6-7(17)4(3-15)19-8(6)14-2-1-5(16)11-9(14)18/h1-2,4,6-8,15,17H,3H2,(H,11,16,18)/t4-,6-,7-,8+/m1/s1InChI=1S/C9H11N5O5/c10-13-12-6-7(17)4(3-15)19-8(6)14-2-1-5(16)11-9(14)18/h1-2,4,6-8,15,17H,3H2,(H,11,16,18)/t4-,6-,7-,8+/m1/s1
MRUKYOQQKHNMFI-JBBNEOJLSA-NMRUKYOQQKHNMFI-JBBNEOJLSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- UZ0
- Homolog
- Q9BZX2
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC230402130 →
- ZINC ZINC20 ZINC230402130 →
- UniProt UniProt Q9BZX2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC230402130”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03141.
PDB 12
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).